Search

Search Constraints

You searched for: Author/Creator Sexton, Joseph

Search Results

21. HLA‐DQ2 is associated with anti‐drug antibody formation to infliximab in patients with immune‐mediated inflammatory diseases. (26th February 2023)

22. Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study. (March 2022)

23. Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy. Issue 8 (29th June 2022)

24. Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study. Issue 1 (28th January 2022)

27. P033 Genomic epidemiology of the antifungal-resistant dermatophytosis epidemic, India, 2017-2019. (20th September 2022)

28. Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study. Issue 2 (26th October 2018)

30. Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial. (26th April 2022)